Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells

Bibliographic Details
Main Authors: Sayantani Mukherjee Chatterjee, Chetan Kumar Jain, Soumen Singha, Piyal Das, Susanta Roychoudhury, Hemanta Kumar Majumder, Saurabh Das
Format: Article
Language:English
Published: American Chemical Society 2018-08-01
Series:ACS Omega
Online Access:http://dx.doi.org/10.1021/acsomega.8b00706
_version_ 1811206449945116672
author Sayantani Mukherjee Chatterjee
Chetan Kumar Jain
Soumen Singha
Piyal Das
Susanta Roychoudhury
Hemanta Kumar Majumder
Saurabh Das
author_facet Sayantani Mukherjee Chatterjee
Chetan Kumar Jain
Soumen Singha
Piyal Das
Susanta Roychoudhury
Hemanta Kumar Majumder
Saurabh Das
author_sort Sayantani Mukherjee Chatterjee
collection DOAJ
first_indexed 2024-04-12T03:48:52Z
format Article
id doaj.art-b3e2418e23a646308670a04413dedada
institution Directory Open Access Journal
issn 2470-1343
language English
last_indexed 2024-04-12T03:48:52Z
publishDate 2018-08-01
publisher American Chemical Society
record_format Article
series ACS Omega
spelling doaj.art-b3e2418e23a646308670a04413dedada2022-12-22T03:49:03ZengAmerican Chemical SocietyACS Omega2470-13432018-08-0138102551026610.1021/acsomega.8b00706Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 CellsSayantani Mukherjee Chatterjee0Chetan Kumar Jain1Soumen Singha2Piyal Das3Susanta Roychoudhury4Hemanta Kumar Majumder5Saurabh Das6†Department of Chemistry (Inorganic Section), Jadavpur University, Kolkata, India‡Cancer Biology & Inflammatory Disorder Division, Indian Institute of Chemical Biology, Kolkata, India∥Department of Physics, Jadavpur University, Kolkata, India†Department of Chemistry (Inorganic Section), Jadavpur University, Kolkata, India‡Cancer Biology & Inflammatory Disorder Division, Indian Institute of Chemical Biology, Kolkata, India§Infectious Diseases and Immunology Division, Indian Institute of Chemical Biology, Kolkata, India†Department of Chemistry (Inorganic Section), Jadavpur University, Kolkata, Indiahttp://dx.doi.org/10.1021/acsomega.8b00706
spellingShingle Sayantani Mukherjee Chatterjee
Chetan Kumar Jain
Soumen Singha
Piyal Das
Susanta Roychoudhury
Hemanta Kumar Majumder
Saurabh Das
Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells
ACS Omega
title Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells
title_full Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells
title_fullStr Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells
title_full_unstemmed Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells
title_short Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells
title_sort activity of coii quinalizarin a novel analogue of anthracycline based anticancer agents targets human dna topoisomerase whereas quinalizarin itself acts via formation of semiquinone on acute lymphoblastic leukemia molt 4 and hct 116 cells
url http://dx.doi.org/10.1021/acsomega.8b00706
work_keys_str_mv AT sayantanimukherjeechatterjee activityofcoiiquinalizarinanovelanalogueofanthracyclinebasedanticanceragentstargetshumandnatopoisomerasewhereasquinalizarinitselfactsviaformationofsemiquinoneonacutelymphoblasticleukemiamolt4andhct116cells
AT chetankumarjain activityofcoiiquinalizarinanovelanalogueofanthracyclinebasedanticanceragentstargetshumandnatopoisomerasewhereasquinalizarinitselfactsviaformationofsemiquinoneonacutelymphoblasticleukemiamolt4andhct116cells
AT soumensingha activityofcoiiquinalizarinanovelanalogueofanthracyclinebasedanticanceragentstargetshumandnatopoisomerasewhereasquinalizarinitselfactsviaformationofsemiquinoneonacutelymphoblasticleukemiamolt4andhct116cells
AT piyaldas activityofcoiiquinalizarinanovelanalogueofanthracyclinebasedanticanceragentstargetshumandnatopoisomerasewhereasquinalizarinitselfactsviaformationofsemiquinoneonacutelymphoblasticleukemiamolt4andhct116cells
AT susantaroychoudhury activityofcoiiquinalizarinanovelanalogueofanthracyclinebasedanticanceragentstargetshumandnatopoisomerasewhereasquinalizarinitselfactsviaformationofsemiquinoneonacutelymphoblasticleukemiamolt4andhct116cells
AT hemantakumarmajumder activityofcoiiquinalizarinanovelanalogueofanthracyclinebasedanticanceragentstargetshumandnatopoisomerasewhereasquinalizarinitselfactsviaformationofsemiquinoneonacutelymphoblasticleukemiamolt4andhct116cells
AT saurabhdas activityofcoiiquinalizarinanovelanalogueofanthracyclinebasedanticanceragentstargetshumandnatopoisomerasewhereasquinalizarinitselfactsviaformationofsemiquinoneonacutelymphoblasticleukemiamolt4andhct116cells